Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

MRNA

Moderna Inc

Jul 26 • 04:00PM ET

122.11

Dollar change +1.71
Percentage change 1.42	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO QQQ VO SPY IVV VUG IBB XLV VOT

Scroll to Statements

Index	NDX, S&P 500	P/E	-	EPS (ttm)	-15.68	Insider Own	12.13%	Shs Outstand	382.00M	Perf Week	0.80%
Market Cap	46.80B	Forward P/E	-	EPS next Y	-5.32	Insider Trans	-1.35%	Shs Float	336.76M	Perf Month	-0.28%
Income	-5968.00M	PEG	-	EPS next Q	-3.35	Inst Own	67.14%	Short Float	6.75%	Perf Quarter	15.00%
Sales	5.14B	P/S	9.10	EPS this Y	42.84%	Inst Trans	0.89%	Short Ratio	5.77	Perf Half Y	18.77%
Book/sh	33.46	P/B	3.65	EPS next Y	24.49%	ROA	-29.22%	Short Interest	22.74M	Perf Year	1.21%
Cash/sh	22.28	P/C	5.48	EPS next 5Y	-	ROE	-37.68%	52W Range	62.55 - 170.47	Perf YTD	22.79%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-20.02%	ROI	-42.54%	52W High	-28.37%	Beta	1.66
Dividend TTM	-	Quick Ratio	3.91	Sales past 5Y	662.08%	Gross Margin	11.10%	52W Low	95.22%	ATR (14)	5.43
Dividend Ex-Date	-	Current Ratio	4.03	EPS Y/Y TTM	-227.99%	Oper. Margin	-100.04%	RSI (14)	46.44	Volatility	3.42% 4.12%
Employees	5600	Debt/Eq	0.10	Sales Y/Y TTM	-65.53%	Profit Margin	-116.00%	Recom	2.44	Target Price	144.32
Option/Short	Yes / Yes	LT Debt/Eq	0.09	EPS Q/Q	-1676.58%	Payout	-	Rel Volume	0.48	Prev Close	120.40
Sales Surprise	79.07%	EPS Surprise	13.68%	Sales Q/Q	-91.07%	Earnings	Aug 01 BMO	Avg Volume	3.94M	Price	122.11
SMA20	1.89%	SMA50	-9.05%	SMA200	15.97%	Trades		Volume	1,884,419	Change	1.42%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-26-24	Downgrade	HSBC Securities	Hold → Reduce	$75 → $86
Jan-02-24	Upgrade	Oppenheimer	Perform → Outperform	$142
Nov-29-23	Initiated	Canaccord Genuity	Hold	$82
Nov-03-23	Upgrade	HSBC Securities	Reduce → Hold	$89 → $69
Nov-02-23	Downgrade	Deutsche Bank	Hold → Sell	$125 → $60
Aug-04-23	Downgrade	TD Cowen	Outperform → Market Perform	$145 → $125
Aug-03-23	Downgrade	Deutsche Bank	Buy → Hold	$125
Jul-24-23	Initiated	William Blair	Mkt Perform	$136.28
Jul-14-23	Initiated	HSBC Securities	Reduce	$97
Jun-26-23	Upgrade	UBS	Neutral → Buy	$221 → $191
Apr-26-23	Initiated	Guggenheim	Neutral
Mar-13-23	Upgrade	TD Cowen	Market Perform → Outperform	$150 → $180
Mar-02-23	Initiated	RBC Capital Mkts	Outperform	$200
Feb-24-23	Downgrade	SVB Securities	Market Perform → Underperform	$111 → $93
Dec-19-22	Upgrade	Jefferies	Hold → Buy	$170 → $275
Dec-14-22	Downgrade	Chardan Capital Markets	Buy → Neutral	$186 → $191
Oct-21-22	Upgrade	SVB Leerink	Underperform → Mkt Perform	$174 → $101
Sep-08-22	Upgrade	Deutsche Bank	Hold → Buy	$165
Feb-01-22	Upgrade	Redburn	Sell → Neutral
Jan-26-22	Upgrade	Deutsche Bank	Sell → Hold	$175

Show Previous Ratings

Today 08:40AM	Moderna (MRNA) Stock Before Q2 Earnings: To Buy or Not to Buy? (Zacks)
03:30AM	This Biotech Risk-Taker Created Moderna. Now Hes Harnessing AI. (Barrons.com)
Jul-25-24 08:00AM	Analog Devices and Flagship Pioneering Announce Strategic Partnership to Accelerate the Development of a Fully Digitized Biological World (PR Newswire)
Jul-24-24 01:18PM	Is Moderna Stock A Sell After Crumbling On Updated RSV Vaccine Results? (Investor's Business Daily)
07:24AM	Novartis invests in bispecifics for cancer; Bob Langer steps down from Moderna board (BioPharma Dive)
05:50PM	Loading…
Jul-23-24 05:50PM	Why Moderna (MRNA) Dipped More Than Broader Market Today (Zacks)
07:00AM	David Rubenstein Joins Moderna's Board of Directors (ACCESSWIRE)
06:00AM	Flagship Pioneering Unveils Abiologics to Pioneer Supranatural Biologics, A New Biotherapeutic Class (PR Newswire)
Jul-18-24 07:00AM	3 Biotech Stocks That Could Be Multibaggers in the Making: July Edition (InvestorPlace)
Jul-17-24 05:50PM	Moderna (MRNA) Stock Moves -0.93%: What You Should Know (Zacks)
08:00AM	Alltrna Announces Updates to Its Board of Directors (PR Newswire)
Jul-16-24 01:33PM	3 Biotech Stocks to Buy in Case of Another Pandemic (InvestorPlace)
10:14AM	Moderna (MRNA) Stock Rises 22% YTD: Time to Buy the Stock? (Zacks)
Jul-15-24 07:13AM	Exploring Melbournes booming life sciences sector (Pharmaceutical Technology)
05:10AM	2 Growth Stocks Down 25% to Buy Right Now (Motley Fool)
06:27AM	Loading…
Jul-14-24 06:27AM	Is Moderna Stock a Buy? (Motley Fool)
Jul-10-24 02:34PM	3 Pharma Stocks That Could Make Your Grandchildren Rich (InvestorPlace)
08:50AM	30 Wealthiest People in France (Insider Monkey)
07:00AM	Moderna to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024 (ACCESSWIRE)
06:00AM	Flagship Pioneering Raises $3.6 Billion to Fuel Breakthrough Innovations that Transform Human Health and Sustainability (PR Newswire)
06:00AM	Flagship Pioneering Expands Leadership Team with Key Appointments and Promotions (PR Newswire)
Jul-09-24 05:50PM	Moderna (MRNA) Stock Sinks As Market Gains: Here's Why (Zacks)
04:12AM	Moderna and Mitsubishi Tanabe link on mRNA vaccines in Japan (Pharmaceutical Technology)
Jul-08-24 07:00PM	Moderna And Mitsubishi Tanabe Pharma Corporation Enter Joint Agreement to Promote Modernas mRNA Respiratory Vaccine Portfolio in Japan, Including COVID-19 Vaccines (ACCESSWIRE)
04:45PM	3 Healthcare Stocks to Sell in July Before They Crash & Burn (InvestorPlace)
09:00AM	The 3 Best Gene Editing Stocks to Buy in July 2024 (InvestorPlace)
Jul-05-24 07:30AM	3 Biotech Stocks to Sell in July Before They Crash & Burn (InvestorPlace)
06:55AM	3 Biotech Stocks Turning DNA Dreams Into Dollars (InvestorPlace)
Jul-03-24 12:49PM	GSK To Spend Up to $1.56B for Rights to Potential COVID-19, Flu Vaccines (Investopedia)
10:18AM	GSK Will Pay Up to $1.5 Billion for CureVacs mRNA Vaccines (Barrons.com)
10:03AM	Loading…
10:03AM	Moderna (MRNA) Secures BARDA Funding for Bird Flu Vaccine (Zacks)
07:08AM	Tesla Deliveries Surprised. 3 Ways Elon Musk Can Drive the Stock Forward. (Barrons.com)
07:00AM	Tesla Deliveries Surprised. 3 Ways Elon Musk Can Drive the Stock Forward and a Few Other Things to Know Today. (Barrons.com)
04:52AM	Modernas mRNA influenza vaccine receives $176m boost (Pharmaceutical Technology)
01:41AM	Moderna Stock (NASDAQ:MRNA): Next-Gen COVID-19 Vaccine Is More Than a Rehash (TipRanks)
Jul-02-24 01:38PM	mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment (Benzinga)
01:33PM	Moderna Gets $176 Million From the U.S. to Make a Bird Flu Vaccine (Barrons.com)
10:34AM	The US will pay Moderna $176 million to develop an mRNA pandemic flu vaccine (Associated Press Finance)
10:29AM	US will pay vaccine maker Moderna $176 million to develop an mRNA-based pandemic flu vaccine (Associated Press Finance)
10:18AM	Moderna gets $176 million from the US to develop an mRNA pandemic bird flu shot (Quartz)
10:03AM	US Inks Vaccine Deal With Moderna as Bird Flu Threat Looms (Bloomberg)
09:59AM	Moderna Receives HHS Grant To Develop a Bird Flu Vaccine (Investopedia)
08:43AM	BARDA hands Moderna $176M to push avian flu vaccine through trials (FierceBiotech.com)
08:04AM	Moderna gets US funding for bird flu vaccine development (BioPharma Dive)
07:30AM	Moderna Receives Project Award through BARDA's Rapid Response Partnership Vehicle Consortium to Accelerate Development of mRNA-based Pandemic Influenza Vaccine (ACCESSWIRE)
Jul-01-24 11:00PM	Surprise! 3 Stocks That Are Outperforming Nvidia in 2024. (InvestorPlace)
10:52AM	CHMP Endorses Moderna's (MRNA) mRNA-based RSV Vaccine (Zacks)
10:24AM	Bird Flu Shot Hopes Dim as Tracing Woes Undercut Covid Lessons (Bloomberg)
07:19AM	EMA CHMP recommends marketing authorisation for Moderna's RSV vaccine (Pharmaceutical Business Review)
Jun-28-24 10:28AM	Treasure Hunt: 3 Biotech Stocks Wall Street Hasn't Discovered Yet (InvestorPlace)
07:00AM	EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna's RSV Vaccine, mRESVIA(R) (ACCESSWIRE)
Jun-27-24 11:10AM	Analyst Report: Moderna, Inc. (Morningstar Research)
11:10AM	Moderna (MRNA) Shares Decline on RSV Vaccine Efficacy Data (Zacks)
08:30AM	RSV vaccine makers shares fall as CDC adjusts shot guidance (BioPharma Dive)
07:30AM	GDP, jobless claims data, Micron earnings tank chip sector: Yahoo Finance (Yahoo Finance Video)
04:27AM	2 Stocks Down More Than 30% to Buy Right Now (Motley Fool)
Jun-26-24 05:58PM	How consumer spending, election impact markets: Market Domination (Yahoo Finance Video) -11.01%
05:05PM	S&P 500 Gains and Losses Today: FedEx Stock Delivers Big Boost After Earnings Beat (Investopedia)
04:13PM	Moderna, Pfizer, and GSK Stocks Fall After Vote on RSV Shots (Barrons.com)
04:12PM	Moderna Dives 11% After RSV Vaccine Proves Less Effective Than Pfizer, GSK Shots (Investor's Business Daily)
03:57PM	Moderna stock dips on 50% RSV vaccine efficacy after 18 months (Yahoo Finance Video)
03:22PM	Lilly joins fellow pharma giants in OpenAI partnership (Pharmaceutical Technology)
02:28PM	Moderna RSV Vaccine Efficacy Sinks Over Time, CDC Documents Show (Bloomberg)
12:54PM	Why Is Moderna Stock Trading Lower On Wednesday? (Benzinga)
12:21PM	Moderna Crumbles After RSV Vaccine Effectiveness Pales Vs. Pfizer, GSK Shots (Investor's Business Daily)
11:57AM	Moderna Shares Fall on RSV Shot Jitters (Barrons.com)
Jun-25-24 05:50PM	Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
01:01AM	Exsilio debuts with $82M, pitching a leap forward for genetic medicine (BioPharma Dive)
Jun-24-24 12:02PM	The FDA awarded a record number of review designations to mRNA vaccines in 2023 (Pharmaceutical Technology)
Jun-20-24 01:32PM	Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval? (Investor's Business Daily)
Jun-18-24 10:19AM	Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment (Benzinga)
Jun-17-24 05:50PM	Moderna (MRNA) Stock Declines While Market Improves: Some Information for Investors (Zacks)
04:33PM	Moderna Stock (NASDAQ:MRNA): Is There Life Beyond Disease Outbreaks? (TipRanks)
Jun-16-24 09:45AM	Moderna Just Gave Investors Another Reason to Buy the Stock (Motley Fool)
Jun-15-24 01:54AM	Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal (Zacks)
Jun-14-24 05:00AM	JPMorgan's Ozempic bet, J&J's baby powder settlement, Moderna's COVID-flu vax: Pharma news round up (Quartz)
04:32AM	Modernas Covid-19 vaccine meets primary efficacy endpoint in Phase III trial (Clinical Trials Arena)
Jun-13-24 07:07AM	Moderna says next-gen COVID shot effective in study (BioPharma Dive)
07:00AM	Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company's Next Generation COVID-19 Vaccine (ACCESSWIRE)
Jun-12-24 12:30PM	7 Struggling Stocks to Sell Before July 2024 (InvestorPlace)
11:53AM	Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine (Clinical Trials Arena)
07:00AM	Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer (PR Newswire)
Jun-11-24 11:53AM	Moderna president: Company outlook 'stabilizing' thanks to new flu-COVID vaccine data (Yahoo Finance)
10:10AM	Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal (Zacks)
06:00AM	3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants (InvestorPlace)
Jun-10-24 05:50PM	Moderna (MRNA) Stock Sinks As Market Gains: Here's Why (Zacks)
04:05PM	Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK (Investor's Business Daily)
01:27PM	Stocks to Watch Monday: Nvidia, Apple, AMD, Southwest Airlines (The Wall Street Journal)
10:53AM	Moderna's COVID-flu combo shot outperformed existing vaccines in a late-stage trial (Quartz)
10:38AM	Moderna CEO on side effects of combination vaccine (CNBC TV)
09:40AM	Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review (Zacks)
08:26AM	Moderna says combination flu, COVID shot succeeds in study (BioPharma Dive)
08:24AM	Moderna's combination flu (CNBC TV)
07:32AM	Midday movers: Southwest Airlines, CrowdStrike, KKR rise; AMD falls (Investing.com)
06:30AM	Moderna Combination Shot Outperforms Standalone Flu, Covid-19 Jabs (Barrons.com)
06:30AM	Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19 (ACCESSWIRE)
05:50AM	Why Moderna Stock Is a No-Brainer Buy Right Now (Motley Fool)
Jun-08-24 06:45AM	3 Reasons to Buy Moderna Stock (Motley Fool)
Jun-07-24 12:05PM	Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season (Benzinga)
10:30AM	Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine (ACCESSWIRE)

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
AFEYAN NOUBAR	Director	Jul 24 '24	Sale	117.80	15,000	1,766,972	2,239,015	Jul 26 07:00 PM
AFEYAN NOUBAR	Director	Jul 17 '24	Sale	122.84	15,000	1,842,651	2,254,015	Jul 19 07:00 PM
Hoge Stephen	President	Jul 15 '24	Sale	121.12	15,000	1,816,800	1,442,089	Jul 16 04:08 PM
AFEYAN NOUBAR	Director	Jul 10 '24	Sale	117.08	15,000	1,756,177	2,269,015	Jul 12 07:00 PM
Mock James M	Chief Financial Officer	Jul 08 '24	Sale	118.24	689	81,465	7,269	Jul 09 04:34 PM
AFEYAN NOUBAR	Director	Jun 26 '24	Sale	127.22	15,000	1,908,293	2,284,015	Jun 28 07:00 PM
AFEYAN NOUBAR	Director	Jun 18 '24	Sale	133.57	15,000	2,003,561	2,299,015	Jun 21 07:00 PM
Hoge Stephen	President	Jun 17 '24	Sale	138.16	15,000	2,072,400	1,457,089	Jun 18 04:05 PM
AFEYAN NOUBAR	Director	Jun 12 '24	Sale	147.20	15,000	2,208,071	2,314,015	Jun 14 07:00 PM
AFEYAN NOUBAR	Director	Jun 11 '24	Sale	148.34	202,832	30,087,339	1,528,557	Jun 11 07:01 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 10 '24	Sale	148.09	5,178	766,785	15,947	Jun 11 04:05 PM
AFEYAN NOUBAR	Director	Jun 05 '24	Sale	151.25	15,000	2,268,804	1,946,931	Jun 07 07:00 PM
Mock James M	Chief Financial Officer	Jun 03 '24	Sale	140.72	691	97,237	6,506	Jun 04 05:27 PM
Hoge Stephen	President	Jun 03 '24	Sale	140.72	339	47,704	1,472,089	Jun 04 05:20 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 03 '24	Sale	140.72	122	17,168	10,878	Jun 04 05:12 PM
AFEYAN NOUBAR	Director	May 29 '24	Sale	145.08	20,000	2,901,585	1,961,931	May 31 07:00 PM
Hoge Stephen	President	May 29 '24	Sale	144.50	341	49,276	1,471,777	May 30 04:14 PM
Mock James M	Chief Financial Officer	May 29 '24	Sale	144.50	183	26,444	5,871	May 30 04:36 PM
Klinger Shannon Thyme	Chief Legal Officer	May 29 '24	Sale	144.50	183	26,444	10,768	May 30 04:27 PM
Klinger Shannon Thyme	Chief Legal Officer	May 28 '24	Sale	162.47	1,296	210,566	10,623	May 29 04:12 PM
Mock James M	Chief Financial Officer	May 28 '24	Sale	162.47	648	105,283	5,726	May 29 04:16 PM
AFEYAN NOUBAR	Director	May 22 '24	Sale	157.57	15,000	2,363,556	1,981,931	May 24 07:00 PM
Hoge Stephen	President	May 15 '24	Sale	127.49	15,000	1,912,350	1,471,508	May 17 04:04 PM
AFEYAN NOUBAR	Director	May 15 '24	Sale	127.32	15,000	1,909,863	1,996,931	May 17 07:00 PM
Hoge Stephen	President	May 10 '24	Sale	120.96	255	30,844	1,486,508	May 13 04:03 PM
AFEYAN NOUBAR	Director	May 08 '24	Sale	121.68	15,000	1,825,220	2,011,931	May 10 07:00 PM
AFEYAN NOUBAR	Director	May 01 '24	Sale	110.92	15,000	1,663,855	2,026,931	May 03 07:00 PM
AFEYAN NOUBAR	Director	Apr 24 '24	Sale	108.32	15,000	1,624,836	2,041,931	Apr 26 07:00 PM
AFEYAN NOUBAR	Director	Apr 17 '24	Sale	103.38	15,000	1,550,703	2,056,931	Apr 19 07:00 PM
Hoge Stephen	President	Apr 15 '24	Sale	105.02	15,000	1,575,300	1,486,241	Apr 16 04:23 PM
AFEYAN NOUBAR	Director	Apr 10 '24	Sale	107.12	15,000	1,606,865	2,071,931	Apr 12 07:00 PM
Mock James M	Chief Financial Officer	Apr 08 '24	Sale	101.93	705	71,859	5,048	Apr 09 04:09 PM
AFEYAN NOUBAR	Director	Apr 03 '24	Sale	101.68	15,000	1,525,268	2,086,931	Apr 05 07:00 PM
AFEYAN NOUBAR	Director	Mar 27 '24	Sale	109.06	15,000	1,635,864	2,101,931	Mar 29 07:00 PM
AFEYAN NOUBAR	Director	Mar 20 '24	Sale	102.39	15,000	1,535,820	2,116,931	Mar 22 07:00 PM
Hoge Stephen	President	Mar 15 '24	Sale	103.17	15,000	1,547,550	1,501,241	Mar 19 04:39 PM
AFEYAN NOUBAR	Director	Mar 13 '24	Sale	108.54	15,000	1,628,031	2,131,931	Mar 15 07:00 PM
Klinger Shannon Thyme	Chief Legal Officer	Mar 08 '24	Sale	99.05	544	53,884	9,267	Mar 11 09:05 AM
Hoge Stephen	President	Mar 04 '24	Sale	94.34	309	29,151	1,516,241	Mar 05 05:52 PM
Klinger Shannon Thyme	Chief Legal Officer	Mar 04 '24	Sale	94.34	117	11,038	8,673	Mar 05 05:56 PM
Hoge Stephen	President	Feb 29 '24	Sale	94.57	2,388	225,838	1,515,898	Mar 01 05:25 PM
Klinger Shannon Thyme	Chief Legal Officer	Feb 29 '24	Sale	94.57	670	63,363	8,557	Mar 01 05:29 PM
Mock James M	Chief Financial Officer	Feb 29 '24	Sale	94.57	647	61,188	4,300	Mar 01 05:33 PM
Hoge Stephen	President	Feb 22 '24	Sale	100.00	15,000	1,500,000	1,513,433	Feb 23 04:04 PM
Bancel Stephane	Chief Executive Officer	Feb 16 '24	Sale	88.88	26,351	2,342,098	5,460,224	Feb 16 04:10 PM
Hoge Stephen	President	Feb 16 '24	Sale	88.88	10,542	936,981	1,528,433	Feb 16 04:19 PM
Hoge Stephen	President	Feb 12 '24	Sale	86.23	304	26,214	1,516,281	Feb 13 04:13 PM
Hoge Stephen	President	Jan 16 '24	Sale	103.90	15,000	1,558,500	1,516,063	Jan 17 04:12 PM
Mock James M	Chief Financial Officer	Jan 08 '24	Sale	109.75	772	84,731	3,632	Jan 09 04:08 PM
Hoge Stephen	President	Dec 27 '23	Sale	100.01	45,000	4,500,450	1,531,063	Dec 28 08:00 AM
Klinger Shannon Thyme	Chief Legal Officer	Dec 08 '23	Sale	79.09	563	44,525	7,912	Dec 11 04:03 PM
Garay Arpa	Chief Commercial Officer	Dec 06 '23	Sale	78.34	564	44,182	3,690	Dec 07 04:21 PM
Hoge Stephen	President	Dec 04 '23	Sale	79.31	309	24,508	1,576,063	Dec 05 04:07 PM
Klinger Shannon Thyme	Chief Legal Officer	Dec 04 '23	Sale	79.31	111	8,804	7,336	Dec 05 04:10 PM
Hoge Stephen	President	Nov 29 '23	Sale	79.81	1,136	90,666	1,575,721	Nov 30 04:11 PM
Hoge Stephen	President	Nov 10 '23	Sale	68.76	263	18,084	1,574,446	Nov 13 04:02 PM
AFEYAN NOUBAR	Director	Nov 01 '23	Sale	76.00	10,000	760,032	2,146,931	Nov 03 07:00 PM
AFEYAN NOUBAR	Director	Oct 25 '23	Sale	76.99	10,000	769,854	2,156,931	Oct 27 07:00 PM
AFEYAN NOUBAR	Director	Oct 11 '23	Sale	103.30	15,000	1,549,441	2,166,931	Oct 13 07:00 PM
Mock James M	Chief Financial Officer	Oct 06 '23	Sale	102.50	2,858	292,953	2,952	Oct 10 04:51 PM
AFEYAN NOUBAR	Director	Oct 04 '23	Sale	102.72	15,000	1,540,845	2,181,931	Oct 06 07:02 PM
AFEYAN NOUBAR	Director	Sep 27 '23	Sale	98.96	10,000	989,646	2,196,931	Sep 29 07:00 PM
AFEYAN NOUBAR	Director	Sep 20 '23	Sale	104.74	15,000	1,571,090	2,206,931	Sep 22 07:00 PM
Hoge Stephen	President	Sep 15 '23	Sale	112.99	15,000	1,694,850	1,574,187	Sep 18 04:06 PM
AFEYAN NOUBAR	Director	Sep 13 '23	Sale	109.70	15,000	1,645,522	2,221,931	Sep 15 07:00 PM
Klinger Shannon Thyme	Chief Legal Officer	Sep 08 '23	Sale	107.22	557	59,722	7,215	Sep 11 04:02 PM
AFEYAN NOUBAR	Director	Sep 06 '23	Sale	107.61	15,000	1,614,094	1,982,209	Sep 08 07:01 PM
Garay Arpa	Chief Commercial Officer	Sep 06 '23	Sale	108.40	574	62,219	3,113	Sep 07 04:46 PM
Hoge Stephen	President	Sep 05 '23	Sale	111.44	320	35,660	1,589,187	Sep 06 04:08 PM
Klinger Shannon Thyme	Chief Legal Officer	Sep 05 '23	Sale	111.44	115	12,815	6,634	Sep 06 04:17 PM
AFEYAN NOUBAR	Director	Aug 30 '23	Sale	115.46	15,000	1,731,951	1,997,209	Sep 01 07:00 PM
Hoge Stephen	President	Aug 29 '23	Sale	115.01	1,135	130,542	1,588,855	Aug 30 04:07 PM
AFEYAN NOUBAR	Director	Aug 23 '23	Sale	115.51	15,000	1,732,613	2,012,209	Aug 25 07:00 PM
Hoge Stephen	President	Aug 17 '23	Sale	100.00	15,000	1,500,000	1,587,579	Aug 18 05:16 PM
AFEYAN NOUBAR	Director	Aug 16 '23	Sale	97.56	10,000	975,614	2,027,209	Aug 18 07:01 PM
Hoge Stephen	President	Aug 10 '23	Sale	102.53	247	25,325	1,602,579	Aug 11 04:18 PM
AFEYAN NOUBAR	Director	Aug 02 '23	Sale	110.99	15,000	1,664,876	2,037,209	Aug 04 07:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MRNA

Moderna Inc

Upgrade your FINVIZ experience